Mayekar RV

No ORCID on file · 2 papers in corpus · active 2019
2019
A Multicenter Phase IV Study to Investigate the Immunogenicity of Recombinant Human Follicle-Stimulating Hormone and Its Impact on Clinical Outcomes in Females Undergoing Controlled Ovarian Stimulation.
Journal of human reproductive sciences ·doi:10.4103/jhrs.jhrs_33_19

ContextTherapeutic proteins can cause immune responses, which may have clinical implications.AimsThe aim of the study was to assess the immunogenicity of recombinant human follicle-stimulating hormone (r-hFSH), when used for controlled ovar…

2019
A Multicenter, Randomized, Equivalence Trial of a New Recombinant Human Chorionic Gonadotropin Preparation versus Ovitrelle® for Ovulation in Women Undergoing Intrauterine Insemination Following Ovarian Stimulation.
Journal of human reproductive sciences ·doi:10.4103/jhrs.jhrs_101_18

ContextA new indigenous recombinant human chorionic gonadotropin (r-hCG) has been developed in India with a comparable pharmacological profile to that of Ovitrelle® (Merck Serono).AimsThis study aims to compare the efficacy and safety of th…